Erschienen: 26.09.2014 Abbildung von Dou | Resistance to Proteasome Inhibitors in Cancer | 2014 | Molecular Mechanisms and Strat...


Resistance to Proteasome Inhibitors in Cancer

Molecular Mechanisms and Strategies to Overcome Resistance

lieferbar ca. 10 Tage als Sonderdruck ohne Rückgaberecht

181,89 €

inkl. Mwst.

auch verfügbar als eBook (PDF) für 149.79 €

2014. Buch. xi, 390 S. 4 s/w-Abbildungen, 51 Farbabbildungen, 17 Farbtabellen, Bibliographien. Hardcover

Springer. ISBN 978-3-319-06751-3

Format (B x L): 15,5 x 23,5 cm

Gewicht: 815 g

In englischer Sprache


The book explores cutting-edge strategies to overcome proteasome inhibitor resistance, including the second generation 20S proteasome inhibitors, novel combinational therapies, and new targets in the ubiquitin-proteasome pathway (e.g., ubiquitin E3 ligases, deubiquitinases, 19S proteasomal ATPases, histone deacetylases, oxidative stress and proteotoxic stress pathways and pharmacogenomic signature profiling) in resistant cancer cells. The mechanisms of action and resistance of proteasome inhibitors, such as bortezomib and carfilzomib in human cancers, including multiple myeloma, mantle cell lymphoma, acute leukemia, and solid tumors are explored in depth in this volume. This timely volume unveils the most current discoveries of the mechanisms behind proteasome inhibitor resistance, which will help illuminate the future of cancer therapies.


  • Dieses Set enthält folgende Produkte:
      Auch in folgendem Set erhältlich:
      • nach oben

        Ihre Daten werden geladen ...